Catherine Doherty

2.6k total citations
26 papers, 1.7k citations indexed

About

Catherine Doherty is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Catherine Doherty has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Molecular Medicine. Recurrent topics in Catherine Doherty's work include Cystic Fibrosis Research Advances (19 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial biofilms and quorum sensing (5 papers). Catherine Doherty is often cited by papers focused on Cystic Fibrosis Research Advances (19 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial biofilms and quorum sensing (5 papers). Catherine Doherty collaborates with scholars based in United Kingdom, Australia and Hungary. Catherine Doherty's co-authors include John R. W. Govan, James W. Nelson, A.K. Webb, J. Maddison, M Dodd, A P Greening, P H Brown, Adam T. Hill, James D. Chalmers and Rosalind L Smyth and has published in prestigious journals such as The Lancet, Nature Genetics and PLoS ONE.

In The Last Decade

Catherine Doherty

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Doherty United Kingdom 18 1.2k 468 348 309 242 26 1.7k
Miles Denton United Kingdom 11 790 0.7× 601 1.3× 202 0.6× 366 1.2× 262 1.1× 22 1.8k
Colin Harbour Australia 16 940 0.8× 621 1.3× 73 0.2× 319 1.0× 145 0.6× 28 1.5k
C.R. Hansen Denmark 20 970 0.8× 1.0k 2.2× 103 0.3× 406 1.3× 385 1.6× 40 2.0k
M E Campbell Canada 17 942 0.8× 851 1.8× 398 1.1× 519 1.7× 171 0.7× 19 1.7k
Lisa A. Carmody United States 15 813 0.7× 717 1.5× 109 0.3× 80 0.3× 233 1.0× 24 1.3k
Mary P. Carroll United Kingdom 24 1.1k 0.9× 842 1.8× 44 0.1× 77 0.2× 292 1.2× 39 1.8k
Christine Segonds France 21 417 0.4× 442 0.9× 287 0.8× 433 1.4× 336 1.4× 40 1.5k
Lisa Cariani Italy 19 373 0.3× 358 0.8× 74 0.2× 211 0.7× 344 1.4× 45 1.2k
Fabio Rossano Italy 25 252 0.2× 402 0.9× 140 0.4× 194 0.6× 333 1.4× 62 1.4k
Micheál Mac Aogáin Ireland 20 611 0.5× 570 1.2× 36 0.1× 178 0.6× 333 1.4× 66 1.6k

Countries citing papers authored by Catherine Doherty

Since Specialization
Citations

This map shows the geographic impact of Catherine Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Doherty more than expected).

Fields of papers citing papers by Catherine Doherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Doherty. The network helps show where Catherine Doherty may publish in the future.

Co-authorship network of co-authors of Catherine Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Doherty. A scholar is included among the top collaborators of Catherine Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Doherty. Catherine Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doherty, Catherine, et al.. (2025). Non-peptidic natural products that target and modulate oxytocin and arginine vasopressin receptors: Opportunities and challenges. Journal of Pharmacological Sciences. 158(3). 238–258. 2 indexed citations
2.
Doherty, Catherine, Lisa Graham‐Wisener, Richard Fallis, et al.. (2023). Immersive virtual reality and psychological well-being in adult chronic physical illness: systematic review. BMJ Supportive & Palliative Care. 14(1). 14–24. 6 indexed citations
3.
Bedi, Pallavi, James D. Chalmers, Catriona Graham, et al.. (2017). A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa. CHEST Journal. 152(2). 368–378. 27 indexed citations
4.
Collie, David, Laura Glendinning, John R. W. Govan, et al.. (2015). Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium. PLoS ONE. 10(11). e0142097–e0142097. 12 indexed citations
5.
Doherty, Catherine, et al.. (2014). Garlic Revisited: Antimicrobial Activity of Allicin-Containing Garlic Extracts against Burkholderia cepacia Complex. PLoS ONE. 9(12). e112726–e112726. 103 indexed citations
6.
Mandal, Pallavi, James D. Chalmers, Catriona Graham, et al.. (2014). Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial. The Lancet Respiratory Medicine. 2(6). 455–463. 62 indexed citations
7.
Collie, David, John R. W. Govan, Steven H. Wright, et al.. (2013). A Lung Segmental Model of Chronic Pseudomonas Infection in Sheep. PLoS ONE. 8(7). e67677–e67677. 14 indexed citations
8.
Chalmers, James D., Brian J. McHugh, Catherine Doherty, et al.. (2013). Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study. The Lancet Respiratory Medicine. 1(3). 224–232. 68 indexed citations
9.
Doherty, Catherine, et al.. (2013). Rapid in situ chondrocyte death induced by Staphylococcus aureus toxins in a bovine cartilage explant model of septic arthritis. Osteoarthritis and Cartilage. 21(11). 1755–1765. 21 indexed citations
10.
Gilchrist, Francis, Catherine Doherty, John R. W. Govan, A.K. Webb, & Andrew Jones. (2011). Pseudomonas aeruginosa bacteraemia in an adult with cystic fibrosis and acute appendicitis. Journal of Cystic Fibrosis. 10(6). 477–478. 2 indexed citations
11.
Murray, M, John R. W. Govan, Catherine Doherty, et al.. (2010). A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 183(4). 491–499. 213 indexed citations
12.
Dodd, Mary, et al.. (2008). The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre. Journal of Cystic Fibrosis. 7(5). 368–372. 20 indexed citations
13.
Jones, Andrew, Mary Dodd, John R. W. Govan, et al.. (2004). Prospective Surveillance for Pseudomonas aeruginosa Cross-Infection at a Cystic Fibrosis Center. American Journal of Respiratory and Critical Care Medicine. 171(3). 257–260. 40 indexed citations
14.
Edenborough, F., et al.. (2004). Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation. Journal of Cystic Fibrosis. 3(1). 37–44. 25 indexed citations
15.
Duncan, Sylvia H., et al.. (1999). Characteristics of sheep-rumen isolates ofPseudomonas aeruginosainhibitory to the growth ofEscherichia coliO157. FEMS Microbiology Letters. 180(2). 305–310. 22 indexed citations
16.
Cheng, Katharine, Rosalind L Smyth, John R. W. Govan, et al.. (1996). Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. The Lancet. 348(9028). 639–642. 319 indexed citations
17.
Davidson, Donald J., Gerry McLachlan, D Lamb, et al.. (1995). Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nature Genetics. 9(4). 351–357. 117 indexed citations
18.
Govan, John R. W., Catherine Doherty, James W. Nelson, et al.. (1993). Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. The Lancet. 342(8862). 15–19. 386 indexed citations
19.
Govan, J. R. W., et al.. (1987). Rational parameters for antibiotic therapy in patients with cystic fibrosis. Infection. 15(4). 300–307. 31 indexed citations
20.
Amyes, Sebastian G. B., et al.. (1986). Trimethoprim and Co-trimoxazole: A Comparison of Their Use in Respiratory Tract Infections. Scandinavian Journal of Infectious Diseases. 18(6). 561–566. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miles Denton Breakdown of academic impact, for papers by Colin Harbour Breakdown of academic impact, for papers by C.R. Hansen Breakdown of academic impact, for papers by M E Campbell Breakdown of academic impact, for papers by Lisa A. Carmody Breakdown of academic impact, for papers by Mary P. Carroll Breakdown of academic impact, for papers by Christine Segonds Breakdown of academic impact, for papers by Lisa Cariani Breakdown of academic impact, for papers by Fabio Rossano Breakdown of academic impact, for papers by Micheál Mac Aogáin
Rankless by CCL
2026